scispace - formally typeset
P

Patricia Marinelli-Casey

Researcher at University of California, Los Angeles

Publications -  35
Citations -  1869

Patricia Marinelli-Casey is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Substance abuse & Psychosocial. The author has an hindex of 23, co-authored 35 publications receiving 1735 citations. Previous affiliations of Patricia Marinelli-Casey include Semel Institute for Neuroscience and Human Behavior & University of Hawaii.

Papers
More filters
Journal ArticleDOI

A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.

TL;DR: Although the superiority of the Matrix approach over TAU was not maintained at the post-treatment timepoints, the in-treatment benefit is an important demonstration of empirical support for this psychosocial treatment approach.
Journal ArticleDOI

An intensive outpatient approach for cocaine abuse treatment: The matrix model

TL;DR: A clear positive relationship was documented between duration and amount of treatment involvement in the Matrix model and positive outcome at 1 year, and further research is underway to provide additional controlled information on the value of this treatment approach.
Journal ArticleDOI

Psychopathology in methamphetamine-dependent adults 3 years after treatment.

TL;DR: This initial investigation of psychiatric diagnoses in MA users after treatment indicates elevated rates of Axis I and II disorders in this population and underscores the need for integrated psychiatric assessment and intervention in drug abuse treatment settings.
Journal ArticleDOI

The matrix model of outpatient stimulant abuse treatment: history and description.

TL;DR: Methamphetamine users appear to respond to treatment similarly to cocaine users and many continue to show improvements at follow-up, supported by several evaluations of the model.
Journal ArticleDOI

Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.

TL;DR: Depressive symptoms declined significantly during treatment and was greatest among those who abstained from MA, and major depression at follow-up was associated with poorer MA use outcomes and impairment across multiple domains of functioning.